Issue 14, 2022

Bimetallic metal–organic frameworks for tumor inhibition via combined photothermal-immunotherapy

Abstract

Herein, we report the design of therapeutic nanoparticles by encapsulating photosensitizers and aluminum ions into metal–organic frameworks. The nanoparticles could significantly inhibit the growth of primary and rechallenged tumors by a combination of photothermal therapy and immunotherapy. This work offers a promising strategy to design an immunologic nanoplatform for “cold” tumor therapy.

Graphical abstract: Bimetallic metal–organic frameworks for tumor inhibition via combined photothermal-immunotherapy

Supplementary files

Article information

Article type
Communication
Submitted
09 Dec 2021
Accepted
18 Jan 2022
First published
19 Jan 2022

Chem. Commun., 2022,58, 2315-2318

Bimetallic metal–organic frameworks for tumor inhibition via combined photothermal-immunotherapy

A. Li, N. Wang, Y. Song, H. Sun, J. Cui, G. Zhang and Q. Yu, Chem. Commun., 2022, 58, 2315 DOI: 10.1039/D1CC06943H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements